<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">The use of convalescent plasma in the treatment of coronaviruses is not new. Convalescent plasma was studied in the treatment of SARS during the 2003 SARS-associated coronavirus 1 (SARS-CoV-1) outbreak originating in Hong Kong. Although the data are mainly limited to case reports [
 <xref rid="bb0155" ref-type="bibr">[31]</xref>, 
 <xref rid="bb0160" ref-type="bibr">[32]</xref>, 
 <xref rid="bb0165" ref-type="bibr">[33]</xref>] and case series [
 <xref rid="bb0170" ref-type="bibr">34</xref>], there are several retrospective, non-randomized studies that offer more substance.
</p>
